Tenax Therapeutics, Inc. (TENX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Tenax Therapeutics, Inc. on December 4, 2024, reporting events occurring on December 2, 2024. The filing addresses a change in senior management regarding the Company's financial leadership.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed relates to executive compensation: the Interim Chief Financial Officer will be compensated at a rate of $410 per hour under an existing consulting agreement with Danforth Advisors, LLC.
Material Changes
- Appointment of Interim CFO: The Board appointed Thomas A. McGauley as Interim Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer, effective December 2, 2024.
- Transition of Duties: Mr. McGauley replaces Lawrence R. Hoffman in these roles. Mr. Hoffman's consultancy services were transitioned to Mr. McGauley on the effective date.
- Compensation Structure: Services are provided as an independent contractor. The hourly rate is subject to an annual increase of up to 4%. The agreement allows for termination with cause immediately or without cause upon 30 days' written notice.
Outlook, Risks, and Management Commentary
The filing contains no forward-looking guidance, market outlook, or discussion of risks and contingencies. Management commentary is limited to the background of the new appointee, noting Mr. McGauley's 25+ years of experience in life sciences finance, including prior interim CFO roles at Galectin Therapeutics and a private life sciences company.
Key Facts for Investor Verification
- Verify the effective date of the CFO transition (December 2, 2024) and the departure of the previous Interim CFO, Lawrence R. Hoffman.
- Review the terms of the Danforth Consulting Agreement (Exhibit 10.1) regarding the $410/hour rate and termination clauses.
- Confirm that no other material financial or operational events were reported in this specific filing.